LAP 07 was sponsored by Groupe Cooperateur Multidisciplinaire en Oncologie. Dr. Hammel reported honoraria from Roche.
Conference Coverage
Chemoimmunotherapy, chemoradiotherapy add no survival in pancreatic cancer
More GI Oncology News
- Pancreatic cystic neoplasms rarely turn cancerous, study shows
- Meta-analysis of postcancer use of immunosuppressive therapies shows no increase in cancer recurrence risk
- Microsimulation model identifies 4-year window for pancreatic cancer screening
- Many preoperative EAC biopsies fail to predict true tumor grade, leading to unnecessary esophagectomy
- Report cards, additional observer improve adenoma detection rate
- Two multitarget stool tests show promise for CRC screening: Studies
- AGA issues CPU for CRC screening, postpolypectomy surveillance
- Gastroenterology Data Trends 2023
Question 1 of 4